Summary: Novartis may have come up with a great new drug but there is another side to this story. The drug is not selling as well as Novartis had hoped. Find out more about the drug, how Novartis is pushing to sell it, and what happened to my patient when an internist prescribed Entresto without consulting the patient's cardiologist.
